BAP31-ELAVL1-SPINK6 axis induces loss of cell polarity and promotes metastasis in hepatocellular carcinoma

  • 0Department of Immunology, Basic Medicine School, The Fourth Military Medical University, Xi'an 710032, Shaanxi, China.

|

|

Summary

This summary is machine-generated.

BAP31 loss of cell polarity in hepatocellular carcinoma (HCC) by regulating ELAVL1-SPINK6 axis, inhibiting metastasis. This finding offers new insights into HCC progression and potential therapeutic targets.

Area Of Science

  • Oncology
  • Cell Biology
  • Molecular Biology

Background

  • Tumor metastasis is a primary cause of death in hepatocellular carcinoma (HCC).
  • Loss of cell polarity in HCC cells is linked to weakened adhesion, epithelial-mesenchymal transition (EMT), and metastasis.
  • The precise mechanisms driving polarity loss in HCC remain incompletely understood.

Purpose Of The Study

  • To elucidate the molecular mechanisms underlying cell polarity loss and metastasis in HCC.
  • To investigate the role of BAP31 in regulating HCC cell polarity and metastatic potential.
  • To identify downstream targets and interacting proteins involved in the BAP31-mediated pathway.

Main Methods

  • RNA sequencing (RNA-seq) to identify downstream genes.
  • Immunoprecipitation-mass spectrometry (IP-MS) and immunofluorescence (IF) assays to detect protein interactions.
  • RNA immunoprecipitation (RIP), RNA-FISH, RNA stability, and luciferase reporter assays to confirm RNA-protein interactions and regulatory effects.
  • In vitro cell assays (invasion, migration) and in vivo experiments in HCC models.

Main Results

  • BAP31 expression correlates with tumor grade and metastasis in HCC.
  • BAP31 silencing restores HCC cell polarity and inhibits invasion and migration.
  • BAP31 interacts with ELAVL1, promoting SPINK6 mRNA stabilization and expression.
  • The BAP31-ELAVL1-SPINK6 axis drives polarity loss and promotes HCC metastasis.

Conclusions

  • The BAP31-ELAVL1-SPINK6 signaling pathway is a key driver of cell polarity loss and metastasis in HCC.
  • Targeting this axis may offer novel therapeutic strategies for preventing HCC metastasis.
  • This study provides critical insights into the molecular mechanisms governing HCC progression.

Related Concept Videos

Cancer Cell Migration through Invadopodia 01:35

2.3K

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Induced Pluripotent Stem Cells 01:06

3.9K

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

The Intrinsic Apoptotic Pathway 01:31

6.0K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...